Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2016 - 2025)

Ligand Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.21 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 23.77% year-over-year to 0.21; the TTM value through Sep 2025 reached 0.21, up 23.77%, while the annual FY2024 figure was 0.19, 14.09% up from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.21 at Ligand Pharmaceuticals, up from 0.2 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.26 in Q1 2023 and bottomed at 0.14 in Q1 2024.
  • The 5-year median for Asset Utilization Ratio is 0.19 (2022), against an average of 0.19.
  • The largest annual shift saw Asset Utilization Ratio surged 83.35% in 2021 before it tumbled 46.27% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.19 in 2021, then rose by 15.21% to 0.22 in 2022, then fell by 22.05% to 0.17 in 2023, then grew by 4.45% to 0.18 in 2024, then rose by 17.55% to 0.21 in 2025.
  • Per Business Quant, the three most recent readings for LGND's Asset Utilization Ratio are 0.21 (Q3 2025), 0.2 (Q2 2025), and 0.2 (Q1 2025).